0000899243-22-001046.txt : 20220105 0000899243-22-001046.hdr.sgml : 20220105 20220105202205 ACCESSION NUMBER: 0000899243-22-001046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 22513314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-03 0 0001645460 Cue Biopharma, Inc. CUE 0001129890 DRISCOLL FREDERICK W C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 12.28 2022-01-03 4 A 0 10000 0.00 A 2032-01-02 Common Stock 10000 10000 D Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. /s/ Fred Driscoll by Colin Sandercock, attorney-in-fact 2022-01-05